New data from ECCMID 2022 shed light on innovations in—and confirm best practices related to—COVID-19 treatments for hospitalized and nonhospitalized patients, COVID-19 vaccination, and long COVID.
Read an expert faculty’s summary of key COVID-19 data presented at ECCMID 2022, including data on antiviral agents, monoclonal antibodies, and IL-6 inhibitors, COVID-19 vaccination, and long COVID.
Hear from CCO’s expert faculty as they present insights on some of the most clinically relevant new COVID-19 data presented at ECCMID 2022, including data on antiviral agents, monoclonal antibodies, IL-6 inhibitors, COVID-19 vaccination, and long COVID.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.